Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
60
¥ millionWording
Avoiding a definitive answer
How definitive the wording is.Items stated in the management plan
Annual updateNet Sales+16.7%
基準 51.4Target60million
Operating profit+1,900.0%
基準 0.2Target4million
Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
Operating profit marginNot disclosed → At least 15% (FY30 structural target)
Only the target level is shown because the current level for comparison was not provided.Key initiatives
01Strengthen the leading market share among local governments and improve the earnings structure through AI
02Continue expanding the number of corporate customers and revenue per customer, while laying the groundwork for sustainable growth
03Lay the groundwork for medium- to long-term business expansion
04Improve productivity and earnings power through the use of AI (cost improvements)
05Drive growth through proprietary data × AI products (revenue generation)
Plan assumptionsMedical expenditure in Japan will be approximately 1.6 times the 2020 level by 2040, The domestic market for health and medical big data is expected to grow 3.5-fold by 2035
Non-financial targetsIndicator name Productivity per employee / Target value Double / Timing Toward fiscal 2030
Size of the Target MarketMarket size and growth rate Data health-related services market: ¥240.5 billion in fiscal 2025, Insurer health promotion services market: approximately ¥700 billion in fiscal 2021, Domestic market related to health and medical big data: approximately ¥200 billion in 2022, projected to reach approximately ¥700 billion in 2035, Estimated target market for the Group: several tens of billions to ¥100 billion / Source 株式会社シードプランニング, "Data Health Market Trends and Insurer Support Services Survey 2023: Direction of Data Health in Phase 3 and Latest Trends among Support Service Providers", 株式会社富士経済, "Current Status and Future Outlook for the Medical AI and Medical Big Data-Related Markets in 2022", Ministry of Health, Labour and Welfare, "Overview of National Medical Care Expenditure for Fiscal 2020" and "Outlook for the Future of Social Security Looking Toward 2040"
Risks identified by the company
Price competition with competitors
Personal Information Leaks
Changes in national or local government policies regarding the optimization of medical expenditure, and amendments to related laws and regulations
Capital and business alliance agreement with DeNA Co.,Ltd.
Material events or similar matters related to the going concern assumption
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan |
| Plan period | 2025–2027 |
| Progress against the plan | Annual update |
| Sales Target | ¥51.4 million → ¥60 million（17%） |
| Operating profit target | ¥0.2 million → ¥4 million |
| Operating profit margin target | Not disclosed → At least 15% (FY30 structural target) |
| Non-financial targets | Indicator name Productivity per employee / Target value Double / Timing Toward fiscal 2030 |
| Plan assumptions | Medical expenditure in Japan will be approximately 1.6 times the 2020 level by 2040, The domestic market for health and medical big data is expected to grow 3.5-fold by 2035 |
| Key initiatives | Strengthen the leading market share among local governments and improve the earnings structure through AI, Continue expanding the number of corporate customers and revenue per customer, while laying the groundwork for sustainable growth, Lay the groundwork for medium- to long-term business expansion, Improve productivity and earnings power through the use of AI (cost improvements), Drive growth through proprietary data × AI products (revenue generation) |
| Size of the Target Market | Market size and growth rate Data health-related services market: ¥240.5 billion in fiscal 2025, Insurer health promotion services market: approximately ¥700 billion in fiscal 2021, Domestic market related to health and medical big data: approximately ¥200 billion in 2022, projected to reach approximately ¥700 billion in 2035, Estimated target market for the Group: several tens of billions to ¥100 billion / Source 株式会社シードプランニング, "Data Health Market Trends and Insurer Support Services Survey 2023: Direction of Data Health in Phase 3 and Latest Trends among Support Service Providers", 株式会社富士経済, "Current Status and Future Outlook for the Medical AI and Medical Big Data-Related Markets in 2022", Ministry of Health, Labour and Welfare, "Overview of National Medical Care Expenditure for Fiscal 2020" and "Outlook for the Future of Social Security Looking Toward 2040" |
| Risks identified | Price competition with competitors, Personal Information Leaks, Changes in national or local government policies regarding the optimization of medical expenditure, and amendments to related laws and regulations, Capital and business alliance agreement with DeNA Co.,Ltd., Material events or similar matters related to the going concern assumption |
| Publication date | 12 May 2026 |
Items this document does not state (13)
Net income targetROE targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorSegment targetResults under the previous planReason for revision or withdrawalDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To achieve steady growth and monetization of existing businesses, while developing specific new businesses to support medium-term expansion. The Company also aims to grow net sales and improve productivity efficiency.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.